Key Points
- Director purchase: Nutex Health director Frank Jaumot bought 150 shares on March 20 at an average price of $93.56 totaling $14,034, a transaction disclosed in an SEC filing.
- Quarterly miss: For the quarter ended March 5, Nutex reported EPS of $1.61 and revenue of $151.68 million, missing analyst estimates ($5.56 EPS; $258.82M revenue), with a net margin of 7.34% and ROE of 17.67%.
- Stock and analyst snapshot: NUTX trades near $95 with a 52-week range of $45.88–$193.07, market cap ~$662M and P/E of 10.58, while analysts show a consensus of "Moderate Buy" and an average target price of $252.50.
Nutex Health Inc. (NASDAQ:NUTX - Get Free Report) Director Frank Jaumot bought 150 shares of the stock in a transaction dated Friday, March 20th. The shares were acquired at an average price of $93.56 per share, with a total value of $14,034.00. Following the completion of the acquisition, the director directly owned 150 shares of the company's stock, valued at approximately $14,034. The trade was a ∞ increase in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.
Nutex Health Stock Performance
Shares of NUTX opened at $94.98 on Tuesday. The company has a quick ratio of 3.39, a current ratio of 3.41 and a debt-to-equity ratio of 0.70. The business's 50 day moving average price is $118.85 and its 200-day moving average price is $125.35. Nutex Health Inc. has a 52 week low of $45.88 and a 52 week high of $193.07. The stock has a market cap of $662.01 million, a P/E ratio of 10.58 and a beta of 0.04.
Nutex Health (NASDAQ:NUTX - Get Free Report) last posted its quarterly earnings data on Thursday, March 5th. The company reported $1.61 earnings per share for the quarter, missing analysts' consensus estimates of $5.56 by ($3.95). The company had revenue of $151.68 million for the quarter, compared to the consensus estimate of $258.82 million. Nutex Health had a net margin of 7.34% and a return on equity of 17.67%.
Institutional Trading of Nutex Health
Institutional investors have recently added to or reduced their stakes in the business. Divisadero Street Capital Management LP bought a new stake in shares of Nutex Health in the 2nd quarter worth $7,481,000. Pacer Advisors Inc. bought a new position in shares of Nutex Health during the third quarter valued at $3,299,000. Geode Capital Management LLC lifted its holdings in shares of Nutex Health by 116.8% during the second quarter. Geode Capital Management LLC now owns 78,859 shares of the company's stock valued at $9,819,000 after purchasing an additional 42,484 shares in the last quarter. Principal Financial Group Inc. purchased a new stake in shares of Nutex Health during the third quarter valued at $962,000. Finally, Segall Bryant & Hamill LLC purchased a new stake in shares of Nutex Health during the third quarter valued at $2,394,000. 5.32% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
Several brokerages have recently weighed in on NUTX. Weiss Ratings restated a "hold (c)" rating on shares of Nutex Health in a report on Monday, December 29th. Wall Street Zen downgraded shares of Nutex Health from a "strong-buy" rating to a "hold" rating in a research report on Saturday, March 7th. Two analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $252.50.
Check Out Our Latest Research Report on Nutex Health
Nutex Health Company Profile
(
Get Free Report)
Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.
The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
